EP2468271
Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.3.2008EP published:
16.7.2014EP application number:
12150107.6
EPO information:
European Patent Register
Max expiry date:
6.3.2028
Title:
Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia
Timeline
Today
7.3.2008EP application
16.7.2014EP Publication
Owner
Name:
Chelsea Therapeutics, Inc.Address:
3530 Toringdon Way Suite 200, 28277, Charlotte, NC, US
Inventor
Name:
Roberts, Michael J.Address:
Charlotte, NC North Carolina, US
Name:
Pedder, SimonAddress:
Fort Mill, SC South Carolina, US
Priority
Number:
894030 PDate:
9.3.2007Country:
US
Classification
Categories:
A61K 31/195, A61K 31/198, A61K 31/277, A61K 31/435, A61P 25/16, A61P 25/00